Agreement includes 15 million doses for delivery in the third quarter of 2022 and 5 million doses for delivery in...
MURFREESBORO, TN / ACCESSWIRE / December 27, 2021 / National Health Investors, Inc. (NYSE:NHI), NHI-REIT of Next House, LLC, Myrtle...
ASHBURN, VA / ACCESSWIRE / December 27, 2021 / Health has long been a growing concern for millions of people...
Total of 27.5 million doses ordered by the Swiss Federal Government to dateCAMBRIDGE, MA / ACCESSWIRE / December 27, 2021...
Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms5-year term deal strengthens...
cPass neutralizing antibody testing seeing increasing demand, questions of infection-acquired immunity, vaccine-acquired immunity and booster shot durability emergeThe Company also...
SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today its...
Castellum Announces Signing of LOI to Acquire $4 million government contractor Castellum, Inc. (OTC: ONOV) announces the signing of a...
To be Published in the International Journal of CardiologySEATTLE, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a muscle...
SAN DIEGO, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients...
NEW ORLEANS and LONDON, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a Company developing...
Pre-specified Interim Analysis Concluded with Recommendation to Continue the ENVASARC Trial Objective Response Rate (ORR) by Blinded Independent Central Review...
FLORHAM PARK, N.J., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived...
HINGHAM, Mass., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has entered into a...
WAYNE, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...
HAIFA, Israel, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) (the “Company”), a leading biotechnology company, today...
Pardes Biosciences Main Protease Pardes Biosciences Main Protease PBI-0451 Pardes Biosciences PBI-0451 Oral Antiviral Pill Pardes NASDAQ Listing Pardes Biosciences...
- ATTRibute-CM did not meet its primary endpoint at Month 12. Mean observed six-minute walk distance (6MWD) decline for the...
MAINZ, Germany, December 27, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder...